Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.

Cancer - 1 Feb 2008

Zlobec Inti, Minoo Parham, Baumhoer Daniel, Baker Kristi, Terracciano Luigi, Jass Jeremy R, Lugli Alessandro

Abstract excerpt

BACKGROUND: The heterogeneity of stage II colon cancer underlines the need for identifying high-risk, lymph node-negative patients. The objective of this study was to define a multimarker prognostic model of 5-year survival in patients with lymph node-negative, mismatch repair (MMR)-proficient colorectal cancer (CRC). METHODS: Immunohistochemistry for 13 tumor markers was performed on 587 lymph node-negative,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD8 Antigens
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Microarray Analysis

Share to Proliferating Cell Nuclear Antigen

Share to Proportional Hazards Models

Share to Receptors, Urokinase Plasminogen Activator

Share to Urokinase-Type Plasminogen Activator

Source

Identifiers

PMID: 18076013
DOI: 10.1002/cncr.23208

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.PMID 18076013Read ↗

Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy.Semantic proximity Read ↗

Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation.Semantic proximity Read ↗

Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.Semantic proximity Read ↗

Combined phenotype of 4 markers improves prognostic value of patients with colon cancer.Semantic proximity Read ↗

Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer.Semantic proximity Read ↗

Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction.Semantic proximity Read ↗

Construction and evaluation of a prognostic risk model of DNA mismatch repair related genes in colorectal cancerSemantic proximity Read ↗

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.